All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • APL-101Phase 21 trial

    Apollomics Inc. · Solid Tumors, Advanced Cancer, Renal Cancer

  • APL-3007Phase 21 trial

    Apellis Pharmaceuticals, Inc. · Geographic Atrophy Secondary to Age-related Macular Degeneration

  • APL-9796Phase 21 trial

    Apollo Therapeutics Ltd · Pulmonary Arterial Hypertension

  • ApomivirFE-L-APO, drug substancePhase 21 trial

    Far East Bio-Tec Co., Ltd · Influenza

  • AR-17043Phase 21 trial

    Alcon Research · Open Angle Glaucoma, Ocular Hypertension

  • ARCT-032Phase 21 trial

    Arcturus Therapeutics, Inc. · Cystic Fibrosis, CFTR Gene Mutation

  • ARCT-2304Phase 21 trial

    Arcturus Therapeutics, Inc. · Influenza, Human

  • ARCT-810Phase 21 trial

    Arcturus Therapeutics, Inc. · OTC Deficiency, Ornithine Transcarbamylase Deficiency, OTCD

  • ARD-501Phase 21 trial

    Aardvark Therapeutics, Inc. · Autism Spectrum Disorder

  • ARD001Phase 21 trial

    Arditus Pte Ltd · Hemophilia A, Healthy Adult Participants

  • ARD103Phase 21 trial

    ARCE Therapeutics, Inc. · Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, MDS (Myelodysplastic Syndrome)

  • ARGX-119Phase 21 trial

    argenx · Spinal Muscular Atrophy (SMA)

  • ARGX-121Phase 21 trial

    argenx · Immunoglobulin A Nephropathy (IgAN)

  • AritinerceptPhase 21 trial

    Aurinia Pharmaceuticals Inc. · Myasthenia Gravis, Generalized

  • ART0380Phase 21 trial

    Artios Pharma Ltd · Advanced Cancer, Metastatic Cancer, Ovarian Cancer

  • ART5803Phase 21 trial

    Arialys Australia Pty Ltd · Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE), Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease, Autoimmune Encephalitis

  • ART6043Phase 21 trial

    Artios Pharma Ltd · Advanced Solid Tumor, Metastatic Solid Tumor

  • ARV-6723Phase 21 trial

    Arvinas Inc. · Advanced Solid Tumor

  • ARV-806Phase 21 trial

    Arvinas Inc. · KRAS G12D Mutation, Advanced Solid Cancer

  • ARX788Phase 21 trial

    Ambrx, Inc. · HER2 Positive Metastatic Breast Cancer

  • AS1986NSPhase 21 trial

    Antelope Surgical Solutions, Inc · Prostate Cancer, Prostate Cancer (Adenocarcinoma), Fluorescence Imaging

  • ASC618Phase 21 trial

    ASC Therapeutics · Hemophilia A

  • ASCA101Phase 21 trial

    MetaFines · Cachexia; Cancer

  • ASK0912Phase 21 trial

    Jiangsu Aosaikang Pharmaceutical Co., Ltd. · Ventilator-associated Bacterial Pneumonia (VABP), Hospital-acquired Bacterial Pneumonia (HABP)

  • AskBio009BAX 335Phase 21 trial

    Takeda · Hemophilia B

  • ASKG712AM712, VIS-101Phase 21 trial

    Visara, Inc. · Neovascular Age-related Macular Degeneration

  • ASKG915Phase 21 trial

    AskGene Pharma, Inc. · Advanced Solid Tumors

  • ASN-3186Phase 21 trial

    Jiangsu Yahong Meditech Co., Ltd aka Asieris · Advanced Solid Tumors

  • ASP2246Phase 21 trial

    Astellas · Chronic Ischemic Stroke

  • ASP2767Phase 21 trial

    Astellas · Glaucoma

  • ASP2957MyoAAV3.8 engineered capsid - myosin heavy chain kinase 7 - human myotubularin, MyoAAV3.8-MHCK7-hMTM1Phase 21 trial

    Astellas · X-linked Myotubular Myopathy

  • ASP2998Phase 21 trial

    Astellas · Locally Advanced or Metastatic Malignant Solid Tumors

  • ASP388BPhase 21 trial

    Astellas · Locally Advanced or Metastatic Solid Tumors

  • ASP5541PRL-02Phase 21 trial

    Astellas · Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer

  • AST-201Phase 21 trial

    Aston Sci. Inc. · Advanced Ovarian Cancer

  • AST-301pNGVL3-hICDPhase 21 trial

    Aston Sci. Inc. · Gastric Cancer

  • ASTX660Phase 21 trial

    Taiho Oncology, Inc. · Solid Tumors, Lymphoma

  • AT-004Phase 21 trial

    Arctic Therapeutics · Acne Vulgaris on the Face

  • AT02Phase 21 trial

    Attralus, Inc. · Amyloidosis; Systemic

  • AT101Anti-CD19 Chimeric Antigen Receptor T cellPhase 21 trial

    AbClon · B-cell Non Hodgkin Lymphoma

  • AT673Phase 21 trial

    Antag Therapeutics · Adults With Overweight/Obesity and Type 2 Diabetes

  • atamparibPhase 21 trial

    Nerviano Medical Sciences (Shanghai) Ltd. · NSCLC Adenocarcinoma, Solid Tumor

  • ATB1651-102Phase 21 trial

    AmtixBio Co., Ltd. · Onychomycosis

  • ATH-063Phase 21 trial

    Athos Therapeutics Inc · Ulcerative Colitis, Inflammatory Bowel Diseases, Autoimmune Diseases

  • ATI-045Phase 21 trial

    Aclaris Therapeutics, Inc. · Atopic Dermatitis, Atopic, Dermatitis

  • atilizumabPhase 21 trial

    Abbisko Therapeutics Co, Ltd · Hepatocellular Carcinoma

  • ATR 1072Phase 21 trial

    Atrium Therapeutics · Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic

  • ATR04-484ATR-04Phase 21 trial

    Azitra Inc. · EGFR Inhibitor-associated Rash

  • ATRN-119Phase 21 trial

    Aprea Therapeutics · Advanced Solid Tumor

  • ATSN-101Phase 21 trial

    Atsena Therapeutics Inc. · Leber Congenital Amaurosis, LCA, LCA1

NewerPage 44 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.